However, another meta-analysis including 35 published articles suggested no associations between GPX1 Pro198Leu polymorphism and cancer risk based on articles with high-quality criteria, whereas strong associations were identified in articles with low-quality criteria [60]. This evidence concerns the gene GPX1 and cancer.